Factors associated with death due to severe acute respiratory syndrome caused by influenza: Brazilian population study

Author(s)

de Morais, Richarlisson B. ; Shimabukuro, Patricia M. S. ; Goncalves, Thayna M. ; Hiraki, Karen R. N. ; Braz-Silva, Paulo H. ; Giannecchini, Simone ; To, Kelvin K. W. ; Barbosa, Dulce A. ; Taminato, Monica

• Document type: Journal article
• Source: JOURNAL OF INFECTION AND PUBLIC HEALTH; v. 15, n. 12, p. 6-pg., 2022-12-01.

Abstract

Introduction: Influenza infection is characterized by acute viral infection of high transmissibility. Worsening of the case can lead to the need for hospitalization, severe acute respiratory syndrome (SARS) and even death. Method: This is a cross-sectional population-based study that used secondary database from the Brazilian Influenza Epidemiological Surveillance Information System. Only cases of adults with diagnosis of influenza by RT-PCR and case evolution recorded were included. Results: We identified 2273 adults with SARS by influenza, 343 of which had death as an outcome. The main risk factors for death were lack of hospitalization, not having cough and age, both with p < 0.001. In addition, without asthma, having black skin color, not receiving flu vaccine, having brown skin color and not having a sore throat (p <= 0.005) were risk factors too. Conclusion: Factors associated with death due to SARS caused by influenza in Brazil, risk factors and protective factors to death were identified. It was evident that those who did not receive the flu vaccine presented twice the risk of unfavorable outcome, reinforcing the need to stimulate adherence to vaccination adhering and propose changes in public policies to make influenza vaccines available to the entire population, in order to prevent severe cases and unfavorable outcomes. (c) 2022 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. (AU)

• FAPESP's process: 21/04492-1 - Serological survey for SARS-CoV-2 and viral detection in children with chronic kidney disease in renal replacement therapy and kidney transplantation
• Grantee: Mônica Taminato
• Support Opportunities: Regular Research Grants